Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

Release Date: September 29, 2022

Expiration Date: September 29, 2023

Activity Overview

This online educational activity is designed to provide an expert disease overview of hidradenitis suppurativa (HS) and interpretation of new and emerging options for diagnosis and treatment, with a forward-looking perspective on how new staging guidelines and novel therapeutic agents might impact clinical practice. A fundamental perspective of the differential diagnosis, staging, and patient-centered management of this disease is presented in a multimedia format, including a series of video interviews with expert thought leaders that are integrated into text-based elements.

Target Audience

This educational activity is directed toward dermatologists, nurse practitioners, physician assistants, nurses, and other health care professionals who are involved in the treatment and management of HS. Primary care providers and women’s health professionals who may be involved in first-line diagnosis of HS are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe characteristic disease features and recommended assessments of a differential diagnosis of HS
• Assess the potential role of emerging therapies for the treatment of HS based on available clinical trial data
• Devise multifaceted and multidisciplinary treatment strategies for patients with HS which are informed by available evidence and individual patient needs

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies, with the following exception (Jennifer Hilton, RN, BSN, associate medical director: Former Consultant: Medtronic; GoCatalant/Pfizer).

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.